Targeting Neuromuscular Junction Regeneration is a Therapeutic Strategy in ALS
Samuele Negro, Chiara Baggio, Giorgia D’Este, Federico Fabris, Giulia Zanetti, Marika Tonellato, Maria Lina Massimino, Alessandro Bertoli, Roberta Schellino, Marina Boido, Monica Favagrossa, Laura Pasetto, Valentina Bonetto, Manuela Basso, Roberto Duchi, , Michela Rigoni
This study shows that targeting NMJ regeneration and CXCR4 can improve motor function and survival in ALS models.
bioRxiv · Jul 13, 2025 · PreprintNeuroscience